Larance, B., Degenhardt, L., Peacock, A., Gisev, N., Mattick, R., Colledge, S., & Campbell, G. (2018). Pharmaceutical opioid use and harm in Australia: The need for proactive and preventative responses. Drug and Alcohol Review, 37(Suppl. 1), S203-S205. doi:10.111/dar.12617

Larance, B., Gisev, N., Cama, E., Nelson, E. C., Darke, S., Larney, S., & Degenhardt, L. (2018). Predictors of transitions across stages of heroin use and dependence prior to treatment-seeking among people in treatment for opioid dependence. Drug and Alcohol Dependence, 191, 145-151 doi:10.1016/j.drugalcdep.2018.03.056

Larney, S., Hickman, M., Fiellin, D. A., Dobbins, T., Nielsen, S., Jones, N. R., Mattick, R. P., Ali, R., & Degenhardt, L. (2018). Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study. BMJ Open, 8(8). doi:10.1136/bmjopen-2018-025204

Lee, Y. Y., Khanh-Dao Le, L., Stockings, E. A., Hay, P., Whiteford, H. A., Barendregt, J. J., & Mihalopoulos, C. (2018). Estimation of a relative risk effect size when using continuous outcomes data: An application of methods in the prevention of major depression and eating disorders. Medical Decision Making, 38(7), 866-880. doi: 10.1177/0272989X18793394

Lees, B., Mewton, L., Stapinski, L., Squeglia, L. M., Rae, C., & Teesson, M. (2018). Binge drinking in young people: Protocol for a systematic review of neuropsychological, neurophysiological and neuroimaging studies. BMJ Open, 8(7). doi:10.1136/bmjopen-2018-023629

Lenton, S., Frank, V. A., Barratt, M. J., Potter, G. R., & Decorte, T. (2018). Growing practices and the use of potentially harmful chemical additives among a sample of small-scale cannabis growers in three countries. Drug and Alcohol Dependence, 192, 250-256. doi:10.1016/j.drugalcdep.2018.07.040

Lilac, S., Gisev, N., Bell, J. S., Korhonen, M. J., & Ilomäki, J. (2018). Predictors of persistent prescription opioid analgesic use among people without cancer in Australia. British Journal of Clinical Pharmacology, 84(6), 1267-1278. doi:10.1111/bcp.13556

Lucke, J., Jensen, C., Dunn, M., Chan, G., Forlini, C., Kaye, S., Partridge, B., Farrell, M., Racine, E., & Hall, W. (2018). Non-medical prescription stimulant use to improve academic performance among Australian university students: Prevalence and correlates of use. BMC Public Health, 18(1). doi: 10.1186/s12889-018-6212-0

Ma, J., Bao, Y. P., Wang, R. J., Su, M. F., Liu, M. X., Li, J. Q., Degenhardt, L., Farrell, M., Blow, F. C., Ilgen, M., Shi, J., & Lu, L. (2018). Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry, Advance online publication, 1-16. doi:10.1038/s41380-018-0094-5

Mattick, R. P., Clare, P. J., Aiken, A., Wadowski, M., Hutchinson, D., Najman, J., Slade, T., Bruno, R., McBride, N., Kypri, K., Vogl, L., & Degenhardt, L. (2018). Association of parental supply of alcohol with adolescent drinking, alcohol-related harms, and alcohol use disorder symptoms: a prospective cohort study. The Lancet Public Health, 3(2), e64-71. doi:10.1016/S2468-2667(17)30240-2

McCoy, J., Bruno, R., & Nielsen, S. (2018). Attitudes in Australia on the upscheduling of over-the-counter codeine to a prescription-only medication. Drug and Alcohol Review, 37(2), 257-261. doi:10.1111/dar.12568